10-Q/A Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2011

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-11-050977`
Period End Date	20110630
Filing Date	20110901
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	gnpb-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 38 Cash Flow Statement 79 Stockholders Equity 18

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$595.00	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
Intellectual property licenses, accumulated amortization	`IntellectualPropertyLicensesNetOfAccumulatedAmortization`	$93.61K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$268.56K	USD	Point-in-time
Intellectual property licenses, accumulated amortization	`IntellectualPropertyLicensesNetOfAccumulatedAmortization`	$57.37K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$209.26K	USD	Point-in-time
Advances to related party	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Advances to related party	`DueFromRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Deposit	`DepositsAssetsCurrent`	$5.00K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Deposit	`DepositsAssetsCurrent`	$7.50K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.45K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$326.06K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	73.64M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	77.66M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $595 and $0	`PropertyPlantAndEquipmentNet`	$16.30K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	73.64M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $595 and $0	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	77.66M	shares	Point-in-time
Intellectual property licenses, net of accumulated amortization of $93,606 and $57,372	`IntellectualPropertyLicensesNet`	$123.80K	USD	Point-in-time
Intellectual property licenses, net of accumulated amortization of $93,606 and $57,372	`IntellectualPropertyLicensesNet`	$160.04K	USD	Point-in-time
Total assets	`Assets`	$466.17K	USD	Point-in-time
Total assets	`Assets`	$1.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$130.64K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$30.29K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$792.58K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$1.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$822.87K	USD	Point-in-time
Common stock, par value $0.000041666; 1,800,000,000 shares authorized; 77,663,349 and 73,638,349 shares issued and outstanding, respectively	`CommonStockValue`	$3.24K	USD	Point-in-time
Common stock, par value $0.000041666; 1,800,000,000 shares authorized; 77,663,349 and 73,638,349 shares issued and outstanding, respectively	`CommonStockValue`	$3.07K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.32M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$11.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-13.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.68M	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$-1.40M	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$638.09K	USD	Point-in-time
Total liabilities and stockholder's equity (deficiency)	`LiabilitiesAndStockholdersEquity`	$466.17K	USD	Point-in-time
Total liabilities and stockholder's equity (deficiency)	`LiabilitiesAndStockholdersEquity`	$1.46M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	15 Qtrs
OPERATING EXPENSES	`OperatingExpenses`	$10.56M	USD	1 Quarter
OPERATING EXPENSES	`OperatingExpenses`	$11.22M	USD	2 Qtrs
OPERATING EXPENSES	`OperatingExpenses`	$152.31K	USD	2 Qtrs
OPERATING EXPENSES	`OperatingExpenses`	$84.63K	USD	1 Quarter
OPERATING EXPENSES	`OperatingExpenses`	$12.11M	USD	15 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-12.11M	USD	15 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-10.56M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-152.31K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-84.63K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-11.22M	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts`	$-563.35K	USD	15 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts`	-	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts`	-	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-304.60K	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-533.83K	USD	15 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-398.56K	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-152.31K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-13.21M	USD	15 Qtrs
NET LOSS	`NetIncomeLoss`	$-10.96M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-84.63K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-11.52M	USD	2 Qtrs
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	2 Qtrs
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	91.97M	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	72.95M	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	74.07M	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	71.86M	shares	1 Quarter

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-152.31K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-13.21M	USD	15 Qtrs
Net loss	`NetIncomeLoss`	$-10.96M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-84.63K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.52M	USD	2 Qtrs
Loss on website	`AmortizationOfWebsite`	$2.12K	USD	2 Qtrs
Loss on website	`AmortizationOfWebsite`	-	USD	2 Qtrs
Loss on website	`AmortizationOfWebsite`	-	USD	15 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$98.17K	USD	15 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$36.80K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$173.00	USD	2 Qtrs
Fair value of vesting of stock options	`StockOptionPlanExpense`	$1.34K	USD	2 Qtrs
Fair value of vesting of stock options	`StockOptionPlanExpense`	$384.26K	USD	2 Qtrs
Fair value of vesting of stock options	`StockOptionPlanExpense`	$498.28K	USD	15 Qtrs
Private placement costs	`PrivatePlacementCosts`	$-563.35K	USD	15 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts`	-	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts`	-	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-304.60K	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-533.83K	USD	15 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-398.56K	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	2 Qtrs
Issuance of shares for services	`ShareBasedCompensation`	$4.20M	USD	2 Qtrs
Issuance of shares for services	`ShareBasedCompensation`	$4.20M	USD	15 Qtrs
Issuance of shares for services	`ShareBasedCompensation`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.96M	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.96M	USD	15 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	15 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	-	USD	2 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	2 Qtrs
Deposit	`IncreaseDecreaseInDepositsOutstanding`	-	USD	2 Qtrs
Deposit	`IncreaseDecreaseInDepositsOutstanding`	-	USD	2 Qtrs
Deposit	`IncreaseDecreaseInDepositsOutstanding`	$-5.00K	USD	15 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-2.50K	USD	15 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$947.00	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-5.00K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.78K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$100.35K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$130.64K	USD	15 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-137.89K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.83M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.52M	USD	15 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$-2.98K	USD	2 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$-16.86K	USD	2 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$-20.86K	USD	15 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.86K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.98K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.86K	USD	15 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$365.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.84M	USD	15 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$873.00K	USD	2 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-23.12K	USD	2 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	15 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	2 Qtrs
Advances to related party	`RepaymentsOfRelatedPartyDebt`	$-50.00K	USD	2 Qtrs
Advances to related party	`RepaymentsOfRelatedPartyDebt`	$-50.00K	USD	15 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.81M	USD	15 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$341.88K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$823.00K	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.02M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$201.01K	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$268.56K	USD	15 Qtrs
CASH AND CASH EQUIVALENTS, Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$268.56K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$209.26K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of period	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of period	`CashAndCashEquivalentsAtCarryingValue`	$268.56K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of period	`CashAndCashEquivalentsAtCarryingValue`	$209.26K	USD	Point-in-time
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	2 Qtrs
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	15 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	2 Qtrs
Forgiveness of debt by Director treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$642.30K	USD	15 Qtrs
Forgiveness of debt by Director treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$642.30K	USD	2 Qtrs
Forgiveness of debt by Director treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	2 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$-1.40M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Common Stock sold in Private Placement at $1.00 per share, January 2011, Amount	`CommonStockSoldInPrivatePlacementAt100PerShareJanuary2011Amount`	$45.00K	USD	2 Qtrs
Common Stock sold in Private Placement at $1.00 per share, April to June 2011, Amount	`CommonStockSoldInPrivatePlacementAt1PerShareAprilToJune2011Amount`	$185.70K	USD	2 Qtrs
Common Stock issued for services, May 2011, Amount	`StockIssuedDuringPeriodValueShareBasedCompensation`	$155.00K	USD	2 Qtrs
Cancellation of shares, Amount	`CancellationOfSharesAmount`	-	USD	2 Qtrs
Fair value of vested stock options and warrants	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$384.26K	USD	2 Qtrs
Fair value of common stock issued to officer for services, Amount	`FairValueOfCommonStockIssuedToOfficerForServicesAmount`	$8.01M	USD	2 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	15 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	-	USD	2 Qtrs
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	2 Qtrs
Net loss for the period	`NetIncomeLoss`	$-152.31K	USD	2 Qtrs
Net loss for the period	`NetIncomeLoss`	$-13.21M	USD	15 Qtrs
Net loss for the period	`NetIncomeLoss`	$-10.96M	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-84.63K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-11.52M	USD	2 Qtrs
Ending Balance Amount	`StockholdersEquity`	$-1.40M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.